Association of type of oral anticoagulation with risk of bleeding in 45,114 patients with venous thromboembolism during initial and extended treatment-A nationwide register-based study.

Katarina Glise Sandblad,Sam Schulman,Annika Rosengren,Jan Sörbo,Jacob Philipson,Per-Olof Hansson

Journal of internal medicine（2023）

引用 0|浏览7

暂无评分

摘要

Apixaban had a lower bleeding risk than warfarin or rivaroxaban during initial treatment. During extended treatment, bleeding risk was similar for apixaban and rivaroxaban, and higher with warfarin.

查看译文

关键词

apixaban, anticoagulants, hemorrhage, rivaroxaban, venous thromboembolism, warfarin

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要